今日药学

2020, v.30(12) 851-853

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Past Issue) | 高级检索(Advanced Search)

临床药师参与1例CKD5期透析合并高尿酸血症患者治疗方案调整的药学实践
Pharmaceutical Practice of Cinical Pharmacist in Therapy Adjustment of A CKD 5D Patient with Hyperuricemia

陈文秀;潘裕华;谢剑腾;赖伟华;
CHEN Wenxiu;PAN Yuhua;XIE Jianteng;LAI Weihua;Department of Pharmacy,Luoding People's Hospital;Guangdong Provincial People's Hospital/Guangdong Academy of Medical Sciences,Department of Pharmacy;Guangdong Provincial People's Hospital/Guangdong Academy of Medical Sciences,Department of Nephrology;

摘要(Abstract):

目的探讨临床药师在CKD5期透析合并高尿酸血症患者临床治疗中发挥的作用。方法通过查阅文献、指南,结合患者的病情特点,在降尿酸治疗时机,药物选择、药物不良反应处理、肾脏替代治疗对尿酸的清除特点等方面对案例进行分析。结果患者的皮疹由非布司他所致,临床药师建议医生及时停药并调整治疗方案。结论临床药师参与临床治疗,可协助医生提高药物治疗水平及保障患者的用药安全。
OBJECTIVE To explore the role of clinical pharmacists in the treatment of patients with CKD5 D and hyperuricemia. METHODS Analyzed the case in terms of the time of treatment for uric acid reduction,drug selection,adverse drug reaction management and renal replacement therapy by reviewing literature,medication history and patient's condition. RESULTS Dermatitis in this case was induced by concurrent use of febuxostat. The clinical pharmacist advised the doctor to stop the drug and adjust the treatment regimes. CONCLUSION The participation of clinical pharmacists in clinical treatment could help doctors improve the level of drug treatment and ensure the medication safety.

关键词(KeyWords): 慢性肾脏病5期;高尿酸血症;降尿酸药物
Chronic kidney disease phase 5D;hyperuricemia;hypouricemics

Abstract:

Keywords:

基金项目(Foundation): 广东省医院药学研究基金(2019A21)

作者(Author): 陈文秀;潘裕华;谢剑腾;赖伟华;
CHEN Wenxiu;PAN Yuhua;XIE Jianteng;LAI Weihua;Department of Pharmacy,Luoding People's Hospital;Guangdong Provincial People's Hospital/Guangdong Academy of Medical Sciences,Department of Pharmacy;Guangdong Provincial People's Hospital/Guangdong Academy of Medical Sciences,Department of Nephrology;

Email:

DOI:

参考文献(References):

扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享